Dougall, William C.
QIMR Berghofer Medical Research Institute
7 papers on CoChatORCID 0000-0001-9487-251X
Most cited papers
- Verified
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature
Immunotherapy and Immune ResponsesT-cell and B-cell Immunology
Cited by 2,290
- Verified
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development
Bone Metabolism and DiseasesT-cell and B-cell Immunology
Cited by 1,478
- Verified
TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma
Guillerey, C., Harjunpää, H., Carrié, N., Kassem, S., Teo, T., Miles, K., Krumeich, S., Weulersse, M., Cuisinier, M., Stannard, K., et al. (2018) · Blood
Multiple Myeloma Research and TreatmentsCancer Immunotherapy and Biomarkers
Cited by 300
- Verified
Molecular pathways: targeting CD96 and TIGIT for cancer immunotherapy
Blake, S. J., Dougall, W. C., Miles, J. J., Teng, M. W. L., & Smyth, M. J. (2016) · Clinical Cancer Research
Immune Cell Function and InteractionCancer Immunotherapy and Biomarkers
Cited by 223
- Verified
Effects of receptor activator of NFκB (RANK) signaling blockade on fracture healing.
Flick, L. M., Weaver, J. M., Ulrich‐Vinther, M., Abuzzahab, F., Zhang, X., Dougall, W. C., Anderson, D., O'Keefe, R. J., & Schwarz, E. M. (2003) · Journal of Orthopaedic Research
Bone Metabolism and DiseasesBone fractures and treatments
Cited by 82
- Verified
Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis
Pellegrini, P., Cordero, A., Gallego, M. I., Dougall, W. C., Purificación, M., Pujana, M. A., & Gonzalez-Suarez, E. (2013) · Stem Cells
Cancer Cells and MetastasisDevelopmental Biology and Gene Regulation
Cited by 52
- Verified
197 POSTER Denosumab is a selective inhibitor of human receptor activator of NF-kB ligand that blocks osteoclast formation in vitro and in vivo
Elliott, R., Kostenuik, P., Chen, C., Kelley, M., Hawkins, N., Housman, J., McCabe, S., Mukku, V., Sullivan, J., & Dougall, W. (2006) · European Journal of Cancer Supplements
Head and Neck Cancer StudiesBone health and treatments
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free